A study of the therapeutic spectrum of a fixed-dose of zotepine and its relationship with serum concentrations of the drug-Reference-Cited by-同舟云学术

A study of the therapeutic spectrum of a fixed-dose of zotepine and its relationship with serum concentrations of the drug

Published:1993-03 Issue:2 Volume:8 Page:133-139
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Kondo Tsuyoshi,Otani Koichi,Ishida Masayuki,Mihara Kazuo,Tanaka Osamu,Kaneko Sunao,Fukushima Yutaka

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference15 articles.

1. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol

2. Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice

3. Serotonin Receptor Subtypes: Implications for Psychopharmacology

4. and (1985). Antipsychotics: plasma levels and clinical response. In: Drugs in Psychiatry, Vol. 3: Antipsychotics, and (eds). Elsevier, Amsterdam, pp. 57-70.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacokinetics of Atypical Antipsychotics: An Update;Clinical Pharmacokinetics;2018-06-19

2. Norzotepine, a Major Metabolite of Zotepine, Exerts Atypical Antipsychotic-Like and Antidepressant-Like Actions through Its Potent Inhibition of Norepinephrine Reuptake;Journal of Pharmacology and Experimental Therapeutics;2010-03-11

3. Early Prediction of Clinical Response in Schizophrenia Patients Receiving the Atypical Antipsychotic Zotepine;The Journal of Clinical Psychiatry;2007-10-15

4. Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2003-09

5. Pharmakokinetik, Interaktionspotential und TDM: Wichtig bei atypischen Antipsychotika;Pharmazie in unserer Zeit;2002-11-04